Desq Long
Sign in
SEC FORM 4
$201,867.48

CRISPR Therapeutics AG (CRSP)

Sale of 4,098 shares at $49.26 per share.

Reporting Person Kulkarni Samarth · Officer Title Chief Executive Officer · Transaction Code S

Traded Oct 14, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001193125-26-423056 · filed 2026-10-15 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "CRISPR Therapeutics AG (CRSP)." Disclosed 2026-10-15. https://desqlong.com/cards/0001193125-26-423056-2 (retrieved 2026-10-16).